Foto del docente

Elisabetta Poluzzi

Professoressa associata

Dipartimento di Scienze Mediche e Chirurgiche

Settore scientifico disciplinare: BIO/14 FARMACOLOGIA

Pubblicazioni

Gatti M.; Fusaroli M.; Raschi E.; Capelli I.; Poluzzi E.; De Ponti F., Crystal nephropathy and amoxicillin: insights from international spontaneous reporting systems, «JN. JOURNAL OF NEPHROLOGY», 2022, 35, pp. 1017 - 1027 [articolo]Open Access

Raschi E.; Diemberger I.; Sabatino M.; Poluzzi E.; De Ponti F.; Potena L., Evaluating sacubitril/valsartan as a treatment option for heart failure with reduced ejection fraction and preserved ejection fraction, «EXPERT OPINION ON PHARMACOTHERAPY», 2022, 23, pp. 303 - 320 [articolo]

Carlotta Lunghi; Michèle Dugas; Jacinthe Leclerc; Elisabetta Poluzzi; Cathy Martineau; Valérie Carnovale; Théo Stéfan; Patrick Blouin; Johanie Lépine; Laura Jalbert; Nataly R Espinoza Suarez; Olha Svyntozelska; Marie-Pier Dery; Giraud Ekanmian; Daniele Maria Nogueira; Pelumi Samuel Akinola; Stéphane Turcotte; Becky Skidmore; Annie LeBlanc;, Global prevalence of antidepressant utilization in the community: A protocol for a systematic review, «BMJ OPEN», 2022, 12, Article number: e062197, pp. 1 - 5 [articolo]

Martini, Silvia; Vitali, Francesca; Capelli, Irene; Donadei, Chiara; Raschi, Emanuel; Aiello, Valeria; Corvaglia, Luigi; De Ponti, Fabrizio; Poluzzi, Elisabetta; Galletti, Silvia, Impact of nephrotoxic drugs on urinary biomarkers of renal function in very preterm infants, «PEDIATRIC RESEARCH», 2022, 91, pp. 1715 - 1722 [articolo]

Di Valerio, Zeno; La Fauci, Giusy; Soldà, Giorgia; Montalti, Marco; Lenzi, Jacopo; Forcellini, Marcello; Barvas, Edoardo; Guttmann, Susanna; Poluzzi, Elisabetta; Raschi, Emanuel; Riccardi, Rossano; Fantini, Maria Pia; Salussolia, Aurelia; Gori, Davide, ROCCA cohort study: Nationwide results on safety of Gam-COVID-Vac vaccine (Sputnik V) in the Republic of San Marino using active surveillance, «ECLINICALMEDICINE», 2022, 49, pp. 101468 - 101478 [articolo]Open Access

Raschi E.; Fusaroli M.; La Placa M.; Ardizzoni A.; Zamagni C.; Poluzzi E.; De Ponti F., Skin Toxicities with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Signals from Disproportionality Analysis of the FDA Adverse Event Reporting System, «AMERICAN JOURNAL OF CLINICAL DERMATOLOGY», 2022, 23, pp. 247 - 255 [articolo]

Baldin E.; Zenesini C.; Antonazzo I.C.; Bartolomei I.; Caniatti L.; Costa M.; Curti E.; Ferraro D.; Foschi M.; Granella F.; Guareschi A.; Immovilli P.; Lugaresi A.; Malagu S.; Mancinelli L.; Montepietra S.; Mussuto V.; Neri W.; Pasquinelli M.; Pellegrino L.; Pesci I.; Poluzzi E.; Pugliatti M.; Ravasio A.; Riise T.; Salvi F.; Santangelo M.; Sireci F.; Sola P.; Strumia S.; Tsantes E.; Vignatelli L.; Vitetta F.; Viti B.; D'Alessandro R., Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy, «NEUROEPIDEMIOLOGY», 2021, 55, pp. 224 - 231 [articolo]

Gatti M.; Ippoliti I.; Poluzzi E.; Antonazzo I.C.; Moro P.A.; Moretti U.; Menniti-Ippolito F.; Mazzanti G.; De Ponti F.; Raschi E., Assessment of adverse reactions to α-lipoic acid containing dietary supplements through spontaneous reporting systems, «CLINICAL NUTRITION», 2021, 40, pp. 1176 - 1185 [articolo]

Raschi, Emanuel; Fusaroli, Michele; Diemberger, Igor; Poluzzi, Elisabetta, Authors’ Reply to Robert P. Giugliano and Colleagues’ Comment on: “Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance”, «DRUG SAFETY», 2021, 44, pp. 505 - 506 [replica/breve intervento]

Gatti M.; Rinaldi M.; Ferraro G.; Toschi A.; Caroccia N.; Arbizzani F.; Raschi E.; Poluzzi E.; Pea F.; Viale P.; Giannella M., Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis, «MYCOSES», 2021, 64, pp. 1317 - 1327 [articolo]

Gatti M.; Rinaldi M.; Ferraro G.; Toschi A.; Caroccia N.; Arbizzani F.; Raschi E.; Poluzzi E.; Pea F.; Viale P.; Giannella M., Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis, «MYCOSES», 2021, 64, pp. 1317 - 1327 [articolo]

Burato S.; Leonardi L.; Antonazzo I.C.; Raschi E.; Ajolfi C.; Baraghini M.; Chiarello A.; Delmonte V.; Di Castri L.; Donati M.; Fadda A.; Fedele D.; Ferretti A.; Gabrielli L.; Gobbi S.; Lughi S.; Mazzari M.; Pieraccini F.; Renzetti A.; Russi E.; Scanelli C.; Zanetti B.; Poluzzi E., Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region, «FRONTIERS IN PHARMACOLOGY», 2021, 11, Article number: 624888, pp. 624888 - 624895 [articolo]Open Access

Luxi N.; Giovanazzi A.; Capuano A.; Crisafulli S.; Cutroneo P.M.; Fantini M.P.; Ferrajolo C.; Moretti U.; Poluzzi E.; Raschi E.; Ravaldi C.; Reno C.; Tuccori M.; Vannacci A.; Zanoni G.; Trifiro G., COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety, «DRUG SAFETY», 2021, 44, pp. 1247 - 1269 [articolo]

Raschi E.; Fusaroli M.; Ardizzoni A.; Poluzzi E.; De Ponti F., Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment, «BREAST CANCER RESEARCH AND TREATMENT», 2021, 186, pp. 219 - 227 [articolo]

Fusaroli M.; Raschi E.; Gatti M.; De Ponti F.; Poluzzi E., Development of a Network-Based Signal Detection Tool: The COVID-19 Adversome in the FDA Adverse Event Reporting System, «FRONTIERS IN PHARMACOLOGY», 2021, 12, Article number: 740707, pp. 1 - 11 [articolo]Open Access